Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

302
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
302
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

303
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
303
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

514
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
514
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

504
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
504
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

209
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
209

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newer Therapeutics to Selectively Kill <i>Clostridioides difficile</i> and Restore the Microbiome.

Infectious disease reports·2026
Same author

Influenza A(H3N2) Subclade K (J.2.4.1): Molecular Characterization, Antigenic Divergence, and Global Spread During the 2025/26 Season.

Infectious disease reports·2026
Same author

Cutaneous Leishmaniasis in the Immunocompromised: Diagnostic and Therapeutic Insights from a Case Documented in Central Italy.

Infectious disease reports·2025
Same author

Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives.

Infectious disease reports·2025
Same author

COVID-19 and Parasitic Co-Infection: A Hypothetical Link to Pulmonary Vascular Disease.

Infectious disease reports·2025
Same author

Comprehensive Analysis of Influenza Viruses' Trends in Italy: Insights from a Nationwide and Regional Perspective.

Infectious disease reports·2025

Related Experiment Video

Updated: Nov 22, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.2K

Clostridioides difficile Infection: A Room for Multifaceted Interventions.

Nicola Petrosillo1, Maria Adriana Cataldo2

  • 1Clinical and Research Department, National Institute for Infectious Diseases "Lazzaro Spallanzani", Via Portuense, 292-00149 Rome, Italy.

Journal of Clinical Medicine
|January 9, 2021
PubMed
Summary

Clostridioides difficile (CD) infections are a major healthcare concern. New strategies are needed to combat this persistent pathogen and improve patient outcomes in healthcare settings.

More Related Videos

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.5K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.9K

Related Experiment Videos

Last Updated: Nov 22, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.2K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.5K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.9K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Clostridioides difficile (CD) is the leading cause of healthcare-associated infections in the United States.
  • CD infections pose a significant threat to patient safety and increase healthcare costs.
  • Effective control and treatment of CD are critical public health priorities.

Discussion:

  • The persistence of CD as a primary healthcare-associated pathogen highlights challenges in current prevention and treatment protocols.
  • Understanding the transmission dynamics and virulence factors of CD is essential for developing targeted interventions.
  • Addressing the rise of antibiotic-resistant strains of CD is crucial for effective management.

Key Insights:

  • CD infections remain a significant and growing problem in healthcare facilities.
  • The economic and clinical burden of CD necessitates urgent attention and innovative solutions.
  • Further research into CD pathogenesis and epidemiology is vital.

Outlook:

  • Future efforts should focus on novel therapeutic approaches and enhanced infection control measures.
  • Development of rapid diagnostics and preventative strategies is a key area for advancement.
  • Collaboration between researchers, clinicians, and policymakers is essential to curb CD infections.